Testicular-Skin Cancer Tradeoff

A genetic mutation tied to risk of developing testicular cancer may be more prevalent in white men because it also confers a reduced risk of developing skin cancer.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Testicular cells showing characteristics of seminoma, or testicular cancerWIKIMEDIA, NEPHRONEvolution may have favored a particular genetic change as humans migrated out of Africa that led to the prevalence of testicular cancer in white men compared to black men, according to researchers in the U.K. Gareth Bond, a molecular biologist at the Ludwig Institute for Cancer Research in Oxford, and colleagues found that a single nucleotide polymorphism (SNP) in a protein acted upon by the p53 gene, mutations in which cause a variety of cancers, can lead to increased melanocyte production when UV light damages cells, thereby protecting skin from further sun damage. But the same mutation also leads to the uncontrolled proliferation of other cells in the body. They reported their findings in Cell on Thursday (October 10).

The suspect protein, called KIT ligand (KITLG), is mutated in 80 percent of Caucasian Europeans but only 24 percent of people of African descent. Testicular cancer is 4–5 times more prevalent in white men than black men, and skin cancers are far more common in people with fairer skin as well. Previous research had identified SNPs in KITLG as major contributors to testicular cancer, and Bond and his colleagues found one such SNP in KITLG that interacted with p53 to regulate cell division.

When the team exposed p53 knockout mice to UV radiation, the rodents could not produce any KITLG. But in wild-type mice, KITLG production doubled upon UV exposure, triggering melanocyte production. This could mean that the deleterious SNP in KITLG was allowed to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies